K Health raises $50 million at $900M valuation for AI-driven primary care platform

K Health, which develops an AI primary care platform, has raised $50 million in funding led by Claure Group, with participation from investors including Pablo Legorreta (founder and CEO of Royalty Pharma), and existing investors Mangrove Capital Partners, Valor Equity Partners, and Atreides Management, LP. The round took K Heath’s total funding to date to $375 million. The company was valued at $900 million in the round after previously reaching a $1.4 billion valuation when it raised a $142 million Series E in 2021. K Health also raised $59 million last July.

Full list of Israeli high-tech funding rounds in 2024

K Health’s primary care solution is available to millions of people in the U.S. through leading health systems and insurers, as well as through a direct-to-consumer mobile app. K Health’s platform includes a medical chat and AI predictive models based on large datasets to help physicians optimize diagnosis and treatment, and focus on patient care.

K Health founders.

"K Health solves the need to make primary care visits highly personalized by giving doctors AI super powers that enable them to practice at the top of their license," said Allon Bloch, founder and CEO of K Health. "Our primary care platform offers a concierge medical experience, with an assigned provider and 24/7 access to care. When partnered with leading health systems like Cedars-Sinai, this model creates significant benefits to access, clinical outcomes, and patient experience. All you need to get care is your health insurance, a stark contrast to concierge medicine services that typically cost thousands of dollars."

The company, which has been developing AI technology for over seven years, employs around 300 people in total, including 100 in Israel.

K Health was founded in 2016 by Allon Bloch, Ran Shaul, Israel Roth and Adam Singolda (CEO of Taboola and board member).